BioDelivery Sciences International logo
BioDelivery Sciences International BDSI

Annual report 2021
added 12-23-2023

report update icon

BioDelivery Sciences International DSO Ratio 2011-2026 | BDSI

Annual DSO Ratio BioDelivery Sciences International

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
115 101 85.9 73.7 36.6 83.8 18.8 29.4 89.8 3.49 11.3

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
115 3.49 59

Quarterly DSO Ratio BioDelivery Sciences International

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - 123 111 107 99.5 106 115 99.6 112 117 119 121 69 87.8 102 90.9 64.6 71.8 92.4 18.3 75.9 91.2 65.1 90.9 7.05 184 131 19.7 113 157 20.6 13.1 64.2 85.1 92.2 93.2 2.39 25.3 2.92 1.72 - 3.46 240 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
240 1.72 83.1

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
37.5 $ 22.5 1.86 % $ 3.73 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 327.16 2.39 % $ 42.9 B usaUSA
Amgen Amgen
AMGN
81.2 $ 349.22 2.71 % $ 188 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 20.4 -0.87 % $ 954 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.18 1.33 % $ 447 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.57 5.59 % $ 3.13 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.48 8.46 % $ 394 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.85 2.41 % $ 9.26 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.71 5.51 % $ 17 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.06 0.99 % $ 6.66 B israelIsrael
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Cerus Corporation Cerus Corporation
CERS
47 $ 1.9 2.99 % $ 362 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
559 $ 1.7 1.8 % $ 199 M usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
9.68 $ 0.36 0.28 % $ 4.12 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
147 - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
59.5 $ 25.57 2.3 % $ 3.13 B usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
52.1 - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
3.66 K - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
60.8 - - $ 2.18 B usaUSA